SYSTEM AND METHOD ENHANCED CANNABINIOD EFFECT DELIVERY

A class of medically-effective formulations comprising cannabinoids, and terpenes, using β-myrcene to improve effectiveness. B-myrcene decreases resistance across the blood-brain barrier for both itself and a plurality of other medically-active compounds such as other terpenes, cannabinoids, and fla...

Full description

Saved in:
Bibliographic Details
Main Authors Adams, Aaron Nicholas, Thacker, Alexander Nelson, Force, Robert Daniel, Vu, Michael Viet Thang, Thacker, JR., Larry Nelson
Format Patent
LanguageEnglish
Published 06.12.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A class of medically-effective formulations comprising cannabinoids, and terpenes, using β-myrcene to improve effectiveness. B-myrcene decreases resistance across the blood-brain barrier for both itself and a plurality of other medically-active compounds such as other terpenes, cannabinoids, and flavonoids. Further, β-myrcene has been determined to raise the saturation level of the cannabinoid receptor CB1 for phytocannabinoids such as delta(9)-tetrahydrocannabinol, and to increase cell membrane permeability for itself as well as cannabinoids, terpenes, flavonoids and other naturally occurring cannabis compounds, thereby improving therapeutic benefits of cannbis formulations.
Bibliography:Application Number: US201715615829